Phase 3 biotech developing oncolytic viral immunotherapies for cancer.
Industry: Health Care
First Day Return: -12.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/25/2021 |
Offer Price | $8.00 |
Price Range $8.00 - $8.00 | |
Offer Shares (mm) | 9.0 |
Deal Size ($mm) | $72 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/26/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $72 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Needham, MA, United States |
Founded | 2003 |
Employees at IPO | 50 |
Website www.candeltx.com |